Lista de obras - Pedro M Machado - Dominio Público Uruguay

2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis

article

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations

artículo científico publicado en 2014

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

artículo científico publicado en 2017

A FRAX model for the estimation of osteoporotic fracture probability in Portugal.

artículo científico publicado en 2013

A stratified model for health outcomes in ankylosing spondylitis

artículo científico publicado en 2011

Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative

artículo científico publicado en 2011

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

artículo científico publicado en 2018

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

scientific article published on 10 November 2010

Ankylosing spondylitis and spinal cord injury

artículo científico publicado en 2008

Ankylosing spondylitis patients with and without psoriasis do not differ in disease phenotype

artículo científico publicado en 2013

Anti-tumor necrosis factor and new bone formation in ankylosing spondylitis: the controversy continues

artículo científico publicado en 2013

Applying science in practice: the optimization of biological therapy in rheumatoid arthritis

artículo científico publicado en 2010

Arthritis and X-linked agammaglobulinemia

scientific article published on 01 October 2008

Association of 17 Definitions of Remission with Functional Status in a Large Clinical Practice Cohort of Patients with Rheumatoid Arthritis

artículo científico publicado en 2019

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

scientific article published on 07 May 2020

Biologics for treating axial spondyloarthritis.

artículo científico publicado en 2018

Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis

article

COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from

artículo científico publicado en 2020

CROSS-CULTURAL VALIDATION OF THE PORTUGUESE VERSION OF THE EDUCATIONAL NEEDS ASSESSMENT TOOL (PortENAT). ⬇️

artículo científico publicado en 2014

Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used: an analysis in the DESIR cohort

artículo científico publicado en 2015

Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria

scientific article published on 05 May 2020

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

artículo científico publicado en 2020

CoReumaPt protocol: the Portuguese cohort of rheumatic diseases

artículo científico publicado en 2012

Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations.

artículo científico publicado en 2018

Conducting research in a pandemic: The power of social media

scientific article published on 21 July 2020

Cross-cultural validation of the Educational Needs Assessment Tool in RA in 7 European countries ⬇️

artículo científico publicado en 2011

Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.

artículo científico publicado en 2017

Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups

artículo científico publicado en 2015

Determining factors related to impaired spinal and hip mobility in patients with axial spondyloarthritis: longitudinal results from the DESIR cohort

artículo científico publicado en 2020

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis

artículo científico publicado en 2019

Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis

artículo científico

Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases

artículo científico publicado en 2015

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches

artículo científico publicado en 2017

Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis

scientific article published on 20 August 2018

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

artículo científico publicado en 2020

Educational needs and preferences of young European clinicians and physician researchers working in the field of rheumatology

artículo científico publicado en 2016

Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis

artículo científico publicado en 2017

Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10.

artículo científico publicado en 2011

EpiReumaPt- the study of rheumatic and musculoskeletal diseases in Portugal: a detailed view of the methodology.

artículo científico publicado en 2015

EpiReumaPt: how to perform a national population based study - a practical guide

artículo científico publicado en 2015

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

artículo científico publicado en 2021

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

scientific article published on 28 May 2019

Frequency and circumstances of falls in people with inclusion body myositis: a questionnaire survey to explore falls management and physiotherapy provision.

artículo científico publicado en 2013

Genetic advances in sporadic inclusion body myositis.

artículo científico

HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis.

artículo científico publicado en 2011

How to measure disease activity in axial spondyloarthritis? ⬇️

artículo científico publicado el 1 de julio de 2011

Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum

artículo científico publicado en 2017

Impact of COVID-19 pandemic on the management of patients with RA: a survey of rheumatologists in six European countries

artículo científico publicado en 2022

Impact of Patient's Global Assessment on Achieving Remission in Patients With Rheumatoid Arthritis: A Multinational Study Using the METEOR Database

scientific article published on 01 October 2019

Increased prevalence of allergic sensitisation in rheumatoid arthritis patients treated with anti-TNFalpha.

artículo científico publicado en 2009

Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries

artículo científico publicado en 2020

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial

artículo científico publicado en 2018

Long-term association between disease activity and disability in early axial spondyloarthritis: results from the DESIR cohort

artículo científico publicado en 2020

MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.

artículo científico publicado en 2015

MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor.

artículo científico publicado en 2012

MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis

scientific article published on 06 October 2011

MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group

artículo científico publicado en 2019

MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis

artículo científico publicado en 2015

Measurements, composite scores and the art of 'cutting-off'

artículo científico publicado en 2016

Measuring Spinal Mobility Using an Inertial Measurement Unit System: A Validation Study in Axial Spondyloarthritis

artículo científico publicado en 2020

Mentoring of young professionals in the field of rheumatology in Europe: results from an EMerging EUlar NETwork (EMEUNET) survey.

artículo científico publicado en 2014

Methotrexate treatment in rheumatoid arthritis: management in clinical remission, common infection and tuberculosis. Results from a systematic literature review.

artículo científico publicado en 2010

Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists [...]

artículo científico publicado en 2010

No relationship between bone mineral density and syndesmophyte formation at the same level in the lumbar spine of patients with radiographic axial Spondyloarthritis

scientific article published on 01 December 2020

Ongoing developments in sporadic inclusion body myositis

artículo científico publicado en 2014

PORTUGUESE RECOMMENDATIONS FOR THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS--2015 UPDATE

article

Portuguese guidelines for the use of biological agents in rheumatoid arthritis - March 2010 update

artículo científico publicado en 2010

Portuguese guidelines for the use of biological agents in rheumatoid arthritis - October 2011 update

artículo científico publicado en 2011

Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 update

article

Portuguese recommendations for the use of methotrexate in the treatment of rheumatoid arthritis

artículo científico publicado en 2009

Portuguese recommendations on "How to diagnose, monitor, and treat undifferentiated peripheral arthritis": systematic review of the literature and the experts' opinion

artículo científico publicado en 2010

Prevalence and social burden of active chronic low back pain in the adult Portuguese population: results from a national survey

artículo científico publicado en 2015

Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey

artículo científico publicado en 2016

Race/ethnicity association with COVID-19 outcomes in rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance Physician Registry

artículo científico publicado en 2020

Response to: 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis' by Györfi et al

scientific article published on 30 June 2020

Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients

scientific article published on 06 October 2020

Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-repor

artículo científico publicado en 2020

Rheumatic disease and COVID-19: epidemiology and outcomes

artículo científico publicado en 2020

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

scientific article published on 16 April 2020

SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry

artículo científico publicado en 2022

Selecting men for bone densitometry: performance of osteoporosis risk assessment tools in Portuguese men.

artículo científico publicado en 2009

Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort

artículo científico publicado en 2011

Spondyloarthritis: Is it time to replace BASDAI with ASDAS?

artículo científico publicado en 2013

Spondyloarthropathies: Sacroiliac joint radiographic progression - speed and determinants

artículo científico publicado en 2016

Sporadic inclusion body myositis: an unsolved mystery.

artículo científico publicado en 2009

Sporadic inclusion body myositis: new insights and potential therapy.

artículo científico publicado en 2014

Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.

artículo científico publicado en 2014

Targeting protein homeostasis in sporadic inclusion body myositis

artículo científico publicado en 2016

The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice

scientific article published on 13 August 2020

The EULAR Outcome Measures Library: development and an example from a systematic review for systemic lupus erythematous instruments

artículo científico publicado en 2015

The Use of Analgesic and Other Pain-Relief Drugs to Manage Chronic Low Back Pain: Results from a National Survey

artículo científico publicado en 2016

The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis

artículo científico publicado en 2015

The value of magnetic resonance imaging and ultrasound in undifferentiated arthritis: a systematic review.

artículo científico publicado en 2011

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force ⬇️

artículo científico publicado en 2017

Update in inclusion body myositis

artículo científico publicado en 2013

Update on outcome assessment in myositis.

artículo científico publicado en 2018

Validation of the educational needs assessment tool as a generic instrument for rheumatic diseases in seven European countries ⬇️

artículo científico publicado en 2013

Who are the young professionals working in the field of rheumatology in Europe and what are their needs? An EMEUNET (EMerging EUlar NETwork) survey

artículo científico publicado en 2012

[Intersticial lung disease as the sole manifestation of antisynthetase syndrome]

scientific article published on 01 April 2009

[Recommendations of the Portuguese Society of Rheumatology: a contribution towards improving the quality of health care]

scientific article published on 01 January 2012

Lista de obras de Pedro M Machado

2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

A FRAX model for the estimation of osteoporotic fracture probability in Portugal.

A stratified model for health outcomes in ankylosing spondylitis

Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

Ankylosing spondylitis and spinal cord injury

Ankylosing spondylitis patients with and without psoriasis do not differ in disease phenotype

Anti-tumor necrosis factor and new bone formation in ankylosing spondylitis: the controversy continues

Applying science in practice: the optimization of biological therapy in rheumatoid arthritis

Arthritis and X-linked agammaglobulinemia

Association of 17 Definitions of Remission with Functional Status in a Large Clinical Practice Cohort of Patients with Rheumatoid Arthritis

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

Biologics for treating axial spondyloarthritis.

Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis

COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from

CROSS-CULTURAL VALIDATION OF THE PORTUGUESE VERSION OF THE EDUCATIONAL NEEDS ASSESSMENT TOOL (PortENAT). ⬇️

Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used: an analysis in the DESIR cohort

Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

CoReumaPt protocol: the Portuguese cohort of rheumatic diseases

Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations.

Conducting research in a pandemic: The power of social media

Cross-cultural validation of the Educational Needs Assessment Tool in RA in 7 European countries ⬇️

Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.

Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups

Determining factors related to impaired spinal and hip mobility in patients with axial spondyloarthritis: longitudinal results from the DESIR cohort

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis

Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis

Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches

Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Educational needs and preferences of young European clinicians and physician researchers working in the field of rheumatology

Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis

Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10.

EpiReumaPt- the study of rheumatic and musculoskeletal diseases in Portugal: a detailed view of the methodology.

EpiReumaPt: how to perform a national population based study - a practical guide

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

Frequency and circumstances of falls in people with inclusion body myositis: a questionnaire survey to explore falls management and physiotherapy provision.

Genetic advances in sporadic inclusion body myositis.

HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis.

How to measure disease activity in axial spondyloarthritis? ⬇️

Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum

Impact of COVID-19 pandemic on the management of patients with RA: a survey of rheumatologists in six European countries

Impact of Patient's Global Assessment on Achieving Remission in Patients With Rheumatoid Arthritis: A Multinational Study Using the METEOR Database

Increased prevalence of allergic sensitisation in rheumatoid arthritis patients treated with anti-TNFalpha.

Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial

Long-term association between disease activity and disability in early axial spondyloarthritis: results from the DESIR cohort

MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study.

MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor.

MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis

MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group

MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis

Measurements, composite scores and the art of 'cutting-off'

Measuring Spinal Mobility Using an Inertial Measurement Unit System: A Validation Study in Axial Spondyloarthritis

Mentoring of young professionals in the field of rheumatology in Europe: results from an EMerging EUlar NETwork (EMEUNET) survey.

Methotrexate treatment in rheumatoid arthritis: management in clinical remission, common infection and tuberculosis. Results from a systematic literature review.

Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists [...]

No relationship between bone mineral density and syndesmophyte formation at the same level in the lumbar spine of patients with radiographic axial Spondyloarthritis

Ongoing developments in sporadic inclusion body myositis

PORTUGUESE RECOMMENDATIONS FOR THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS--2015 UPDATE

Portuguese guidelines for the use of biological agents in rheumatoid arthritis - March 2010 update

Portuguese guidelines for the use of biological agents in rheumatoid arthritis - October 2011 update

Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 update

Portuguese recommendations for the use of methotrexate in the treatment of rheumatoid arthritis

Portuguese recommendations on "How to diagnose, monitor, and treat undifferentiated peripheral arthritis": systematic review of the literature and the experts' opinion

Prevalence and social burden of active chronic low back pain in the adult Portuguese population: results from a national survey

Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey

Race/ethnicity association with COVID-19 outcomes in rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance Physician Registry

Response to: 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis' by Györfi et al

Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients

Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-repor

Rheumatic disease and COVID-19: epidemiology and outcomes

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries